Zhengye Biotechnology Holding (ZYBT) Enterprise Value (2023 - 2025)
Historic Enterprise Value for Zhengye Biotechnology Holding (ZYBT) over the last 3 years, with Q2 2025 value amounting to $6.6 million.
- Zhengye Biotechnology Holding's Enterprise Value changed N/A to $6.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was $6.6 million, marking a year-over-year change of. This contributed to the annual value of $7.0 million for FY2024, which is 2527.12% up from last year.
- Latest data reveals that Zhengye Biotechnology Holding reported Enterprise Value of $6.6 million as of Q2 2025.
- In the past 5 years, Zhengye Biotechnology Holding's Enterprise Value registered a high of $7.0 million during Q4 2024, and its lowest value of $5.4 million during Q4 2023.
- For the 3-year period, Zhengye Biotechnology Holding's Enterprise Value averaged around $6.3 million, with its median value being $6.6 million (2025).
- The largest annual percentage gain for Zhengye Biotechnology Holding's Enterprise Value in the last 5 years was 2767.14% (2024), contrasted with its biggest fall of 2767.14% (2024).
- Over the past 3 years, Zhengye Biotechnology Holding's Enterprise Value (Quarter) stood at $5.4 million in 2023, then grew by 27.67% to $7.0 million in 2024, then dropped by 5.49% to $6.6 million in 2025.
- Its Enterprise Value stands at $6.6 million for Q2 2025, versus $7.0 million for Q4 2024 and $5.4 million for Q4 2023.